References
- UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998 352 9131 837 853 9742976
- UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 1998 352 9131 854 865 9742977
- Pyorala K Pedersen TR Kjekshus J Faergeman O Olsson AG Thorgeirsson G Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 1997 20 4 614 620 9096989
- Collins R Armitage J Parish S Sleigh P Peto R Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 2003 361 9374 2005 2016 12814710
- Goldberg RB Mellies MJ Sacks FM Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators Circulation 1998 98 23 2513 2519 9843456
- Sever PS Poulter NR Dahlof B Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial–lipid-lowering arm (ASCOT-LLA) Diabetes Care 2005 28 5 1151 1157 15855581
- Colhoun HM Betteridge DJ Durrington PN Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 2004 364 9435 685 696 15325833
- American Diabetes Association Standards of medical care in diabetes–2011 Diabetes Care 2011 34 Suppl 1 S11 S61 21193625
- Handelsman Y Mechanick JI Blonde L American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan Endocr Pract 2011 17 Suppl 2 1 53 21474420
- Ong KL Cheung BM Wong LY Wat NM Tan KC Lam KS Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999–2004 Ann Epidemiol 2008 18 3 222 229 18201902
- Fonseca VA Rosenstock J Wang AC Truitt KE Jones MR Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy Diabetes Care 2008 31 8 1479 1484 18458145
- Bays HE Goldberg RB Truitt KE Jones MR Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects Arch Intern Med 2008 168 18 1975 1983 18852398
- Goldberg RB Fonseca VA Truitt KE Jones MR Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy Arch Intern Med 2008 168 14 1531 1540 18663165
- Goldfine AB Fonseca VA Jones MR Wang AC Ford DM Truitt KE Long-term safety and tolerability of colesevelam HCl in subjects with type 2 diabetes Horm Metab Res 2010 42 1 23 30 19862667
- Rosenstock J Fonseca VA Garvey WT Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes Endocr Pract 2010 16 4 629 640 20634175
- Davidson MH Donovan JM Misir S Jones MR A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia Am J Cardiovasc Drugs 2010 10 5 305 314 20860413
- Bays H Dujovne C Colesevelam HCl: a non-systemic lipid-altering drug Expert Opin Pharmacother 2003 4 5 779 790 12740000
- Bays HE Goldberg RB The ‘forgotten’ bile acid sequestrants: is now a good time to remember? Am J Ther 2007 14 6 567 580 18090882
- Insull WJr Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review South Med J 2006 99 3 257 273 16553100